Skip to main content

Advertisement

SpringerLink
Log in

Differentiating recurrent Guillain–Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review

  • Review article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Guillain–Barre syndrome (GBS) is an acute-onset immune-mediated polyneuropathy characterized by ascending symmetrical muscle weakness, diminished reflexes, and sensory symptoms. While GBS typically follows a monophasic course, some patients experience treatment-related fluctuations or recurrences, posing diagnostic challenges in distinguishing GBS from acute-onset chronic inflammatory polyneuropathy (A-CIDP). A-CIDP, may present acutely, simulating GBS, with a nadir in less than 8 weeks, subsequently evolving into a chronic or relapsing course. The distinction between recurrent GBS and A-CIDP is crucial, as A-CIDP necessitates long-term immunosuppression. A PubMed search was conducted using the search terms ‘recurrent Guillain Barre syndrome’ and ‘acute onset CIDP’ focusing on studies in the English language, published between January 1, 2004 and April 30, 2023. Overlapping clinical features, particularly in the early stages, complicate differentiation between recurrent GBS and CIDP. Electrophysiological studies, ultrasonography, and immunological markers have been explored for discrimination; however, definitive criteria for differentiation remain elusive. Recent follow-up studies have further blurred the boundaries between recurrent GBS and A-CIDP, suggesting the persistence of underlying immune processes even in GBS patients without clinical deterioration. This emphasizes the necessity of reevaluating diagnostic criteria and treatment strategies. In conclusion, distinguishing recurrent GBS from A-CIDP remains an ongoing challenge. Existing evidence questions the categorization of recurrent GBS as a distinct entity, challenging its very existence. Continued research is necessary to refine diagnostic criteria and deepen our understanding of these conditions, ultimately advancing patient care. This review delves into the intricacies of recurrent GBS and A-CIDP differentiation and highlights the need for a reevaluation of the recurrent GBS concept.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ruts L, van Koningsveld R, van Doorn PA (2005) Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology 65(1):138–140. https://doi.org/10.1212/01.wnl.0000167549.09664.b8

    Article  PubMed  Google Scholar 

  2. Yuki N, Hartung HP (2012) Guillain-Barre syndrome. N Engl J Med 366(24):2294–2304. https://doi.org/10.1056/NEJMra1114525

    Article  CAS  PubMed  Google Scholar 

  3. Shahrizaila N, Lehmann HC, Kuwabara S (2021) Guillain-Barre syndrome. Lancet 397(10280):1214–1228. https://doi.org/10.1016/S0140-6736(21)00517-1

    Article  CAS  PubMed  Google Scholar 

  4. McGrogan A, Madle GC, Seaman HE, de Vries CS (2009) The epidemiology of Guillain-Barre syndrome worldwide a systematic literature review. Neuroepidemiology 32(2):150–163. https://doi.org/10.1159/000184748

    Article  PubMed  Google Scholar 

  5. Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011) Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology 36(2):123–133. https://doi.org/10.1159/000324710

    Article  PubMed  Google Scholar 

  6. Doets AY, Verboon C, van den Berg B et al (2018) Regional variation of Guillain-Barre syndrome. Brain 141(10):2866–2877. https://doi.org/10.1093/brain/awy232

    Article  PubMed  Google Scholar 

  7. Bae JS, Yuki N, Kuwabara S et al (2014) Guillain-Barre syndrome in Asia. J Neurol Neurosurg Psychiatry 85(8):907–913. https://doi.org/10.1136/jnnp-2013-306212

    Article  PubMed  Google Scholar 

  8. Leonhard SE, van der Eijk AA, Andersen H et al (2022) An international perspective on preceding infections in Guillain-Barre syndrome: the IGOS-1000 cohort. Neurology 99(12):e1299–e1313. https://doi.org/10.1212/WNL.0000000000200885

    Article  PubMed  Google Scholar 

  9. McDonnell EP, Altomare NJ, Parekh YH et al (2020) COVID-19 as a trigger of recurrent Guillain-Barre syndrome. Pathogens. https://doi.org/10.3390/pathogens9110965

    Article  PubMed  PubMed Central  Google Scholar 

  10. de Castro G, Bastos PG, Martinez R, de Castro Figueiredo JF (2006) Episodes of Guillain-Barré syndrome associated with the acute phase of HIV-1 infection and with recurrence of viremia. Arq Neuropsiquiatr 64(3a):606–8. https://doi.org/10.1590/s0004-282x2006000400016

    Article  PubMed  Google Scholar 

  11. Fotiadou A, Tsiptsios D, Karatzetzou S, Kitmeridou S, Iliopoulos I (2022) Acute-onset chronic inflammatory demyelinating polyneuropathy complicating SARS-CoV-2 infection and Ad26.COV2.S vaccination: report of two cases. Egypt J Neurol Psychiatr Neurosurg 58(1):116. https://doi.org/10.1186/s41983-022-00515-4

    Article  PubMed  PubMed Central  Google Scholar 

  12. Bellucci M, Germano F, Grisanti S et al (2022) Case report: post-COVID-19 vaccine recurrence of Guillain-Barre syndrome following an antecedent parainfectious COVID-19-related GBS. Front Immunol 13:894872. https://doi.org/10.3389/fimmu.2022.894872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Suri V, Pandey S, Singh J, Jena A (2021) Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination. BMJ Case Rep. https://doi.org/10.1136/bcr-2021-245816

    Article  PubMed  PubMed Central  Google Scholar 

  14. Leonhard SE, Munts AG, van der Eijk AA, Jacobs BC (2018) Acute-onset chronic inflammatory demyelinating polyneuropathy after Zika virus infection. J Neurol Neurosurg Psychiatry 89(10):1118–1119. https://doi.org/10.1136/jnnp-2017-317346

    Article  PubMed  Google Scholar 

  15. Yang B, Lian Y, Liu Y, Wu BY, Duan RS (2016) A retrospective analysis of possible triggers of Guillain-Barre syndrome. J Neuroimmunol 293:17–21. https://doi.org/10.1016/j.jneuroim.2016.02.003

    Article  CAS  PubMed  Google Scholar 

  16. Huang C, Zhang Y, Deng S, Ren Y, Lu W (2020) Trauma-related Guillain-Barre syndrome: systematic review of an emerging concept. Front Neurol 11:588290. https://doi.org/10.3389/fneur.2020.588290

    Article  PubMed  PubMed Central  Google Scholar 

  17. Leonhard SE, Mandarakas MR, Gondim FAA et al (2019) Diagnosis and management of Guillain-Barre syndrome in ten steps. Nat Rev Neurol 15(11):671–683. https://doi.org/10.1038/s41582-019-0250-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Verboon C, Doets AY, Galassi G et al (2019) Current treatment practice of Guillain-Barre syndrome. Neurology 93(1):e59–e76. https://doi.org/10.1212/WNL.0000000000007719

    Article  PubMed  Google Scholar 

  19. Alessandro L, Castiglione JI, Brand P, Bruno V, Barroso F (2022) Treatment-related fluctuations in Guillain-Barre syndrome​: clinical features and predictors of recurrence. Arq Neuropsiquiatr 80(5):516–522. https://doi.org/10.1590/0004-282X-ANP-2021-0226

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ruts L, Drenthen J, Jacobs BC, van Doorn PA, Dutch GBSSG (2010) Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology 74(21):1680–6. https://doi.org/10.1212/WNL.0b013e3181e07d14

    Article  CAS  PubMed  Google Scholar 

  21. Das A, Kalita J, Misra UK (2004) Recurrent Guillain Barre’ syndrome. Electromyogr Clin Neurophysiol 44(2):95–102

    CAS  PubMed  Google Scholar 

  22. Wang S, Luo Z, Peng T (2022) Serum thyroid-stimulating hormone is an independent risk factor of recurrent Guillain-Barre syndrome. Muscle Nerve 65(6):688–692. https://doi.org/10.1002/mus.27539

    Article  CAS  PubMed  Google Scholar 

  23. Dalakas MC, Medscape, (2011) Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 7(9):07–17. https://doi.org/10.1038/nrneurol.2011.121

    Article  Google Scholar 

  24. Van den Bergh PY, Hadden RD, Bouche P et al (2010) European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 17(3):356–363. https://doi.org/10.1111/j.1468-1331.2009.02930.x

    Article  PubMed  Google Scholar 

  25. Alessandro L, Pastor Rueda JM, Wilken M et al (2018) Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients. J Peripher Nerv Syst. 23(3):154–8. https://doi.org/10.1111/jns.12266

    Article  CAS  PubMed  Google Scholar 

  26. Anadani M, Katirji B (2015) Acute-onset chronic inflammatory demyelinating polyneuropathy: an electrodiagnostic study. Muscle Nerve 52(5):900–905. https://doi.org/10.1002/mus.24667

    Article  PubMed  Google Scholar 

  27. Basta I, Bozovic I, Berisavac I et al (2019) Recurrent Guillain-Barre syndrome—case Series. Neurol India 67(6):1536–1538. https://doi.org/10.4103/0028-3886.273649

    Article  PubMed  Google Scholar 

  28. Ishii J, Yuki N, Kawamoto M, Yoshimura H, Kusunoki S, Kohara N (2016) Recurrent Guillain-Barre syndrome, Miller Fisher syndrome and Bickerstaff brainstem encephalitis. J Neurol Sci 364:59–64. https://doi.org/10.1016/j.jns.2016.03.008

    Article  PubMed  Google Scholar 

  29. Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA (2009) Recurrent Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 80(1):56–59. https://doi.org/10.1136/jnnp.2008.156463

    Article  CAS  PubMed  Google Scholar 

  30. Chohan S, Chohan A (2022) Recurrence of a rare subtype of Guillain-Barre syndrome following a second dose of the shingles vaccine. Cureus 14(10):e30717. https://doi.org/10.7759/cureus.30717

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yelam A, Nagarajan E, Govindarajan R, Bollu PC (2018) A Rare case of recurrent Guillain-Barre syndrome without albuminocytological dissociation. BMJ Case Rep. https://doi.org/10.1136/bcr-2018-226572

    Article  PubMed  PubMed Central  Google Scholar 

  32. Jo YS, Choi JY, Chung H, Kim Y, Na SJ (2018) Recurrent Guillain-Barre syndrome following urinary tract infection by Escherichia coli. J Korean Med Sci 33(4):e29. https://doi.org/10.3346/jkms.2018.33.e29

    Article  PubMed  Google Scholar 

  33. Mossberg N, Nordin M, Movitz C et al (2012) The recurrent Guillain-Barre syndrome: a long-term population-based study. Acta Neurol Scand 126(3):154–161. https://doi.org/10.1111/j.1600-0404.2012.01667.x

    Article  CAS  PubMed  Google Scholar 

  34. Ling L, Bagshaw SM, Villeneuve PM (2021) Guillain-Barre syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barre syndrome. CMAJ 193(46):E1766–E1769. https://doi.org/10.1503/cmaj.210947

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Imam K, Liu A (2020) A case of recurrent Guillain-Barre syndrome observed by the same clinician 12 years apart. Clin Case Rep 8(8):1376–1378. https://doi.org/10.1002/ccr3.2903

    Article  PubMed  PubMed Central  Google Scholar 

  36. Togawa J, Nakaoku Y, Hagiwara M et al (2015) Similarities of serum anti-ganglioside antibodies in first and third episodes of recurrent Guillain-Barre syndrome: case report. J Neurol 262(5):1360–1362. https://doi.org/10.1007/s00415-015-7714-7

    Article  PubMed  Google Scholar 

  37. Dy M, Leshner RL, Crawford JR (2013) An unusual case of recurrent guillain-barre syndrome of a different subtype five years after initial diagnosis. Case Rep Neurol Med 2013:356157. https://doi.org/10.1155/2013/356157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Yalinay Dikmen P, Emre Oge A (2012) Recurrent GBS with GD1a anti-ganglioside antibodies. J Peripher Nerv Syst 17(1):135–7. https://doi.org/10.1111/j.1529-8027.2012.00384.x

    Article  PubMed  Google Scholar 

  39. Notturno F, Kokubun N, Sekiguki Y et al (2016) Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes. J Neurol Sci 365:132–136. https://doi.org/10.1016/j.jns.2016.02.053

    Article  PubMed  Google Scholar 

  40. Takemoto K, Kawahara M, Atagi K (2023) Recurrent Guillain-Barre syndrome associated with the second episode of campylobacter jejuni infection: a case report. Intern Med. https://doi.org/10.2169/internalmedicine.1094-22

    Article  PubMed  PubMed Central  Google Scholar 

  41. Griffin G, Cunningham B, Beary JM, Spolter Y, Gandee R, Newey CR (2021) Lighting strikes twice: recurrent Guillain-Barre Syndrome (GBS) after influenza vaccination. Case Rep Neurol Med 2021:6690643. https://doi.org/10.1155/2021/6690643

    Article  PubMed  PubMed Central  Google Scholar 

  42. Takahashi H, Kimura T, Yuki N, Yoshioka A (2018) An adult case of recurrent Guillain-Barre syndrome with anti-galactocerebroside antibodies. Intern Med 57(3):409–412. https://doi.org/10.2169/internalmedicine.8941-17

    Article  PubMed  Google Scholar 

  43. Pyun SY, Jeong JH, Bae JS (2015) Recurrent Guillain-Barre syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery. Clin Neurol Neurosurg 139:230–233. https://doi.org/10.1016/j.clineuro.2015.10.022

    Article  PubMed  Google Scholar 

  44. Heckmann JG, Dütsch M (2012) Recurrent Miller Fisher syndrome: clinical and laboratory features. Eur J Neurol 19(7):944–954. https://doi.org/10.1111/j.1468-1331.2011.03584.x

    Article  CAS  PubMed  Google Scholar 

  45. Hwang J, Kwon YJ, Kim JK, Kim NJ, Baek SH (2019) Recurrent Guillain-Barre syndrome with anti-GT1a and anti-GQ1b ganglioside antibodies. J Clin Neurol 15(3):404–406. https://doi.org/10.3988/jcn.2019.15.3.404

    Article  PubMed  PubMed Central  Google Scholar 

  46. Martic V, Lepic T (2007) Recurrence of childhood Guillain-Barre syndrome after a long asymptomatic interval: a case report. J Clin Neuromuscul Dis 9(1):256–261. https://doi.org/10.1097/CND.0b013e3181563d90

    Article  PubMed  Google Scholar 

  47. Bekircan-Kurt C.E., F. Yildiz, C. Temucin, A. Tuncer Kurne, E. Tan, S. Erdem Ozdamar. 2017 Recurrent peripheral and central demyelination in a seronegative patient. in Peripheral Nerve Society Annual Meeting. Barcelona, Spain.

  48. Doneddu PE, Bianchi E, Cocito D et al (2020) Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits data from the Italian CIDP database. Eur J Neurol 27(1):136–43. https://doi.org/10.1111/ene.14044

    Article  CAS  PubMed  Google Scholar 

  49. Abraham H, Kuzhively J, Rizvi SW (2017) Chronic inflammatory demyelinating polyneuropathy (CIDP): an uncommon manifestation of systemic lupus erythematosus (SLE). Am J Case Rep 18:980–983. https://doi.org/10.12659/ajcr.903541

    Article  PubMed  PubMed Central  Google Scholar 

  50. Vialatte de Pemille C, Noel N, Adam C et al (2023) Red flags for chronic inflammatory demyelinating polyradiculoneuropathy associated with sarcoidosis or connective tissue diseases. J Clin Med. https://doi.org/10.3390/jcm12093281

    Article  PubMed  PubMed Central  Google Scholar 

  51. Julio PR, Cortes MMM, Costallat LTL, Gaino JZ, Franca MC Jr, Appenzeller S (2021) Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus. Semin Arthritis Rheum 51(1):158–165. https://doi.org/10.1016/j.semarthrit.2020.09.018

    Article  CAS  PubMed  Google Scholar 

  52. Toledano P, Orueta R, Rodriguez-Pinto I, Valls-Sole J, Cervera R, Espinosa G (2017) Peripheral nervous system involvement in systemic lupus erythematosus: Prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre. Autoimmun Rev 16(7):750–755. https://doi.org/10.1016/j.autrev.2017.05.011

    Article  CAS  PubMed  Google Scholar 

  53. Kuitwaard K, van der Pol WL, Ruts L, van Doorn PA (2009) Individual patients who experienced both Guillain-Barre syndrome and CIDP. J Peripher Nerv Syst 14(1):66–68. https://doi.org/10.1111/j.1529-8027.2009.00208.x

    Article  PubMed  Google Scholar 

  54. Rajabally YA, Peric S, Bozovic I et al (2021) Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: a European collaborative study. Muscle Nerve 64(6):657–661. https://doi.org/10.1002/mus.27374

    Article  CAS  PubMed  Google Scholar 

  55. Mansour M, Ouerdiene A, Bedoui I, Kacem A, Zaouali J, Mrissa R (2020) Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerves and respiratory tract involvement: a case report. Clin Case Rep 8(11):2199–2203. https://doi.org/10.1002/ccr3.3087

    Article  PubMed  PubMed Central  Google Scholar 

  56. Dennis E, Hartman E, Cortes-Penfield N, Piccione E, Thaisetthawatkul P (2023) Acute and Chronic demyelinating neuropathies after COVID-19 vaccination: a report of 4 cases. J Clin Neuromuscul Dis 24(3):147–156. https://doi.org/10.1097/CND.0000000000000418

    Article  PubMed  Google Scholar 

  57. Klehmet J, Marschenz S, Ruprecht K et al (2018) Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP). Clin Chem Lab Med 56(6):919–926. https://doi.org/10.1515/cclm-2017-0792

    Article  CAS  PubMed  Google Scholar 

  58. Patnaik AP, Mininni J, Porter NC, Morris NA (2021) A severe course of relapsing-remitting acute-onset chronic inflammatory demyelinating polyneuropathy in a young man. Case Rep Neurol 13(1):73–77. https://doi.org/10.1159/000511956

    Article  PubMed  PubMed Central  Google Scholar 

  59. Kim W, An JY (2021) Vaccination-associated acute-onset chronic inflammatory demyelinating polyneuropathy followed by acute disseminated encephalomyelitis in a postpartum woman. Acta Neurol Belg 121(3):771–774. https://doi.org/10.1007/s13760-020-01468-2

    Article  PubMed  Google Scholar 

  60. Bert-Marcaz C, Briantais A, Faucher B et al (2022) Expanding the spectrum of VEXAS syndrome: association with acute-onset CIDP. J Neurol Neurosurg Psychiatry 93(7):797–798. https://doi.org/10.1136/jnnp-2021-327949

    Article  PubMed  Google Scholar 

  61. Lim JY, Lim YH, Choi EH (2016) Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: a case report. Medicine (Baltimore) 95(49):e5580. https://doi.org/10.1097/MD.0000000000005580

    Article  PubMed  Google Scholar 

  62. Martin-Aguilar L, Lleixa C, Pascual-Goni E (2022) Autoimmune nodopathies, an emerging diagnostic category. Curr Opin Neurol 35(5):579–585. https://doi.org/10.1097/WCO.0000000000001107

    Article  CAS  PubMed  Google Scholar 

  63. Van den Bergh PYK, van Doorn PA, Hadden RDM et al (2021) European academy of neurology/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. Eur J Neurol 28(11):3556–3583. https://doi.org/10.1111/ene.14959

    Article  PubMed  Google Scholar 

  64. Liu B, Zhou L, Sun C et al (2023) Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody. Ann Clin Transl Neurol 10(6):944–952. https://doi.org/10.1002/acn3.51775

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Hadden RD (2009) Deterioration after Guillain-Barré syndrome: recurrence, treatment-related fluctuation or CIDP? J Neurol Neurosurg Psychiatry 80(1):3. https://doi.org/10.1136/jnnp.2008.160069

    Article  PubMed  Google Scholar 

  66. Dionne A, Nicolle MW, Hahn AF (2010) Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 41(2):202–207. https://doi.org/10.1002/mus.21480

    Article  PubMed  Google Scholar 

  67. Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS (2015) Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 51(6):846–852. https://doi.org/10.1002/mus.24484

    Article  PubMed  Google Scholar 

  68. Grimm A, Oertl H, Auffenberg E et al (2019) Differentiation between Guillain-Barré syndrome and acute-onset chronic inflammatory demyelinating polyradiculoneuritis-a prospective follow-up study using ultrasound and neurophysiological measurements. Neurotherapeutics 16(3):838–847. https://doi.org/10.1007/s13311-019-00716-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Breville G, Lascano AM, Roux-Lombard P, Vuilleumier N, Lalive PH (2021) Interleukin 8, a biomarker to differentiate Guillain-Barre syndrome from CIDP. Neurol Neuroimmunol Neuroinflamm. https://doi.org/10.1212/NXI.0000000000001031

    Article  PubMed  PubMed Central  Google Scholar 

  70. Comi C (2011) Fas-mediated T-cell apoptosis in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 16(Suppl 1):45–47. https://doi.org/10.1111/j.1529-8027.2011.00306.x

    Article  PubMed  Google Scholar 

  71. Sung JY, Tani J, Park SB, Kiernan MC, Lin CS (2014) Early identification of “acute-onset” chronic inflammatory demyelinating polyneuropathy. Brain 137(Pt 8):2155–2163. https://doi.org/10.1093/brain/awu158

    Article  PubMed  PubMed Central  Google Scholar 

  72. Guemy C, Durand MC, Brisset M, Nicolas G (2023) Changes in electrophysiological findings suggestive of demyelination following Guillain-Barre syndrome: a retrospective study. Muscle Nerve. https://doi.org/10.1002/mus.27803

    Article  PubMed  Google Scholar 

  73. Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS (2014) Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy. Clin Neurophysiol 125(3):635–641. https://doi.org/10.1016/j.clinph.2013.08.014

    Article  CAS  PubMed  Google Scholar 

  74. Comi C, Osio M, Ferretti M et al (2009) Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP. J Peripher Nerv Syst 14(2):101–106. https://doi.org/10.1111/j.1529-8027.2009.00219.x

    Article  PubMed  Google Scholar 

  75. Zivkovic SA, Peltier AC, Iacob T, Lacomis D (2011) Chronic inflammatory demyelinating polyneuropathy and ventilatory failure: report of seven new cases and review of the literature. Acta Neurol Scand 124(1):59–63. https://doi.org/10.1111/j.1600-0404.2010.01431.x

    Article  CAS  PubMed  Google Scholar 

  76. Min YG, Hong YH (2020) Treatment-related fluctuations in subacute inflammatory demyelinating polyneuropathy. ENeurologicalSci. https://doi.org/10.1016/j.ensci.2020.100224

    Article  PubMed  PubMed Central  Google Scholar 

  77. Kuitwaard K, Bos-Eyssen ME, Blomkwist-Markens PH, van Doorn PA (2009) Recurrences, vaccinations and long-term symptoms in GBS and CIDP. J Peripher Nerv Syst 14(4):310–315. https://doi.org/10.1111/j.1529-8027.2009.00243.x

    Article  PubMed  Google Scholar 

  78. Oh SJ, Lu L, Alsharabati M, Morgan MB, King P (2020) Chronic inflammatory axonal polyneuropathy. J Neurol Neurosurg Psychiatry 91(11):1175–1180. https://doi.org/10.1136/jnnp-2020-323787

    Article  PubMed  Google Scholar 

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

    Berin Inan, Can Ebru Bekircan-Kurt, Sevim Erdem-Ozdamar & Ersin Tan

  2. Department of Neurology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey

    Berin Inan

  3. Private Neurology Practice, Ankara, Turkey

    Mehmet Demirci

Authors
  1. Berin Inan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Can Ebru Bekircan-Kurt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehmet Demirci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sevim Erdem-Ozdamar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ersin Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Berin Inan.

Ethics declarations

Conflict of interest

None.

Ethical approval

Not applicable.

Informed consent

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inan, B., Bekircan-Kurt, C.E., Demirci, M. et al. Differentiating recurrent Guillain–Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review. Acta Neurol Belg (2024). https://doi.org/10.1007/s13760-024-02557-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13760-024-02557-2

Keywords

Search

Navigation